Publication | Closed Access
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
67
Citations
31
References
2015
Year
This study strongly suggests that AT7519 is a promising drug for the treatment of high-risk neuroblastoma patients with MYCN amplification.
| Year | Citations | |
|---|---|---|
Page 1
Page 1